ERSOT
ALNY icon

Employees Retirement System of Texas’s Alnylam Pharmaceuticals ALNY Stock Holding History

Employees Retirement System of Texas’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Hold
8,403
– – 0.02% 177
2026
Q1 		$2.78M Sell
8,403
-1,389
-14% -$473K 0.02% 154
2025
Q4 		$3.89M Hold
9,792
– – 0.03% 161
2025
Q3 		$4.46M Buy
9,792
+318
+3% +$129K 0.04% 161
2025
Q2 		$3.09M Buy
+9,474
New +$2.62M 0.03% 215
2025
Q1 		– Sell
-8,403
Closed -$1.98M – 269
2024
Q4 		$1.98M Hold
8,403
– – 0.02% 234
2024
Q3 		$2.31M Buy
8,403
+686
+9% +$179K 0.02% 240
2024
Q2 		$1.88M Hold
7,717
– – 0.02% 233
2024
Q1 		$1.15M Buy
7,717
+3,956
+105% +$660K 0.01% 268
2023
Q4 		$720K Buy
+3,761
New +$641K 0.01% 287
2022
Q3 		– Sell
-11,018
Closed -$1.61M – 364
2022
Q2 		$1.61M Hold
11,018
– – 0.02% 562
2022
Q1 		$1.8M Hold
11,018
– – 0.02% 577
2021
Q4 		$1.87M Hold
11,018
– – 0.02% 564
2021
Q3 		$2.08M Hold
11,018
– – 0.02% 561
2021
Q2 		$1.87M Hold
11,018
– – 0.02% 586
2021
Q1 		$1.56M Hold
11,018
– – 0.02% 628
2020
Q4 		$1.43M Hold
11,018
– – 0.02% 545
2020
Q3 		$1.6M Hold
11,018
– – 0.02% 541
2020
Q2 		$1.63M Hold
11,018
– – 0.02% 523
2020
Q1 		$1.2M Hold
11,018
– – 0.02% 541
2019
Q4 		$1.27M Hold
11,018
– – 0.02% 649
2019
Q3 		$886K Buy
+11,018
New +$872K 0.01% 743

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Employees Retirement System of Texas's ALNY Position: Q2 2026 in Review

Employees Retirement System of Texas held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 8,403 shares worth $2.53M. The position accounts for 0.02% of the portfolio, ranked #177.

Employees Retirement System of Texas first reported a position in ALNY in Q3 2019 and has held it in 22 quarters since. The position peaked at $4.46M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Employees Retirement System of Texas held 8,403 shares of Alnylam Pharmaceuticals worth $2.53M as of Q2 2026.
  • Employees Retirement System of Texas left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.02% of Employees Retirement System of Texas's portfolio in Q2 2026, its #177 holding.
  • Employees Retirement System of Texas first reported a position in Alnylam Pharmaceuticals in Q3 2019 and has held it in 22 quarters since.
  • Employees Retirement System of Texas's Alnylam Pharmaceuticals position peaked at $4.46M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.